Age-related macular degeneration | Antibody treatment for HIV

Supplement for macular degeneration; antibodies suppressed HIV for several months; exposure to new things primes the brain to learn

Having trouble viewing this email? View it as a Web page.

June 14, 2022 Edition

Two children obstructed by black splotch in center

Improved dietary supplement for age-related macular degeneration

Replacing a component of a dietary supplement for treating age-related macular degeneration improved its safety and efficacy over a 10-year period.

T cell covered with numerous virus particles

Combination antibody treatment for HIV

A combination of anti-HIV antibodies suppressed the virus for several months without the need for daily antiretroviral therapy.

Illustrations of two similar cartoon creatures.

Priming the brain to learn

After people were incidentally exposed to new objects, they learned to categorize them faster when explicitly taught to recognize them later.

Connect with us:

Facebook

RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

June 14, 2022 Edition

Improved dietary supplement for age-related macular degeneration

Combination antibody treatment for HIV

Priming the brain to learn

Popular Stories:

Connect with us: